Concepedia

Antje Richter

AR

Statistics

Publications

32

Citations

1K

H-Index

21

Active since

2005

Affiliations

Justus-Liebig-Universität Gießen(Current)

Charité - Universitätsmedizin Berlin

Universities of Giessen and Marburg Lung Center

Max Delbrück Center

German Center for Lung Research

Antje Richter is an author at Justus-Liebig-Universität Gießen specializing in molecular oncology, oncology, and epigenetics.

Publications per year

2005–2023

32

Publications

32

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma

Bernhard Gillissen, Jana Wendt, Antje Richter et al. · The Journal of Cell Biology · 2010 · 68 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences

Undraga Schagdarsurengin, Antje Richter, Juliane Hornung et al. · Molecular Cancer · 2010 · 60 citations · Full text

Life Sciences, Genetics, Oncology +9

The tumor suppressor RASSF1A induces the YAP1 target gene <i>ANKRD1</i> that is epigenetically inactivated in human cancers and inhibits tumor growth

Adriana P. Jiménez, Annalena Traum, Thomas Boettger et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Genetics, Molecular Biology +17

Frequent epigenetic inactivation of RASSF10 in thyroid cancer

Undraga Schagdarsurengin, Antje Richter, Christina Wöhler et al. · Epigenetics · 2009 · 52 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma

Bernhard Gillissen, Anja Richter, Antje Richter et al. · Journal of Biological Chemistry · 2017 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 32